Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Opioids Market - Growth, Trends and Forecasts (2019-2024): Rising Focus on Abuse-deterrent Formulation (ADF) by Generic Manufacturers - ResearchAndMarkets.com

May 9, 2019

DUBLIN--(BUSINESS WIRE)--May 9, 2019--The “Opioids Market - Growth, Trends, and Forecast (2019-2024)” report has been added to ResearchAndMarkets.com’s offering.

Due to an increase in the incidence of medical ailments, the market studied is expected to grow over the forecast period.

Strong Agonists are Expected to Hold the Largest Market Share in the Receptor Binding Segment

In the receptor binding segment of the opioids market, the strong agonist category is expected to have the largest market size. This segment is expected to witness a CAGR of 5.02% in the forecast period. An agonist is a drug that triggers certain receptors in the brain. Methadone (strong) agonist therapy is an effective treatment for addiction to opioid drugs (such as heroin).

Strong agonist opioids activate opioid receptors, and after binding tightly, undergo significant conformational changes. Strong agonists include codeine, fentanyl, heroin, hydrocodone, methadone, morphine, and oxycodone. As per the US Department of Health and Human Services and National Institutes of Health, in 2015, 25.4 million Americans adults experienced pain daily. This statistic indicates the importance of pain management and impacts the opioid market positively.

North America Dominates the Market and is Expected to Continue to Dominate in the Forecast Period

North America currently dominates the market for opioids and is expected to continue its strong hold for a few more years. Codeine and morphine are the most commonly prescribed opioids for cancer patients to relieve pain. However, illegal use of fentanyl to relieve pain is rising across the United States.

Recently, in 2018, despite the escalating trade war between the United States and China, medical and law enforcement officials and politicians tried to stop illegally mailed fentanyl from China to the United States. Some of the major companies in the United States market include Teva, Janssen, Insys, and Mylan. However, some of these companies have been involved in legal actions instituted against them for persuading doctors to influence sales of opioids to boost the market.

In the past two years, initiatives and campaigns have been initiated under the Centers for Disease Control and Prevention and Federal government to fight the opioid epidemic. Due to these actions, growth of the studied market is expected to steadily slow down over the forecast period.

Competitive Landscape

The opioids market consists of several players. In terms of market share, few of the players currently dominate the market. However, with the rising usage of the opioids in medicines, more companies are trying to enter this market, especially in the emerging markets. However, strict laws and stringent regulatory policies are deterring market penetration by small- and mid-sized companies.

Allergan, Teva Pharmaceuticals, Mallinckrodt, Insys Therapeutics, and Amneal Pharmaceuticals Inc. hold a substantial market share of the opioids market.

Key Topics Covered


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Prevalence of Orthopedic Diseases & Chronic Pain

4.2.2 Inclination toward Extended Release Formulations from Immediate Release of Opioids

4.2.3 Rising Focus on Abuse-deterrent Formulation (ADF) by Generic Manufacturers

4.2.4 Growing Palliative Care Facilities

4.3 Market Restraints

4.3.1 Advent and Legalization of Cannabis as an Alternative to Opioids

4.3.2 Prescription Drug Abuse

4.4 Porter’s Five Force Analysis


5.1 Product Type

5.1.1 Codeine

5.1.2 Fentanyl

5.1.3 Morphine

5.1.4 Meperidine

5.1.5 Methadone

5.1.6 Other Product Types

5.2 Receptor Binding

5.2.1 Strong Agonist

5.2.2 Mild to Moderate Agonist

5.3 Application

5.3.1 Pain Management Cancer Pain Neuropathic Pain Osteoarthritis Pain Other Pain Managements

5.3.2 Cold and Cough

5.3.3 Diarrhoea

5.3.4 Other Applications

5.4 Geography

5.4.1 North America

5.4.2 Europe

5.4.3 Asia Pacific

5.4.4 Middle East & Africa

5.4.5 South America


6.1 Company Profiles

6.1.1 Allergan plc

6.1.2 Mallinckrodt LLC

6.1.3 Purdue Pharma L.P.

6.1.4 Rhodes Technologies L.P.

6.1.5 Sun Pharmaceutical Industries Ltd.

6.1.6 Teva Pharmaceutical

6.1.7 Vertice Pharma LLC

6.1.8 Johnson and Johnson

6.1.9 INSYS Therapeutics

6.1.10 Hikma Pharmaceuticals plc

6.1.11 Endo Pharmaceuticals Inc.

6.1.12 Egalet Corporation

6.1.13 Amneal Pharmaceuticals


For more information about this report visit https://www.researchandmarkets.com/r/4p1lz9

View source version on businesswire.com:https://www.businesswire.com/news/home/20190509005731/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Analgesics



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/09/2019 12:01 PM/DISC: 05/09/2019 12:02 PM